Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

NCT02202408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: SKI2670
DRUG: Placebo

Sponsor

SK Chemicals Co., Ltd.